Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The impact of phosphodiesterase‐5 inhibition or angiotensin‐converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload

Pharmacology Research & Perspectives(2024)10.1002/prp2.1172Source: DataRank Database

The impact of phosphodiesterase‐5 inhibition or angiotensin‐converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload is a research paper published in Pharmacology Research & Perspectives (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.15)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Matúš Miklovič ORCID,Martin Kotrč ORCID,Petra Škaroupková,L Kazdová ORCID,Jaroslava Trnovská ORCID

Live enrichment

PubMed:38284173 PMC:PMC10823410 OpenAlex:https://openalex.org/W4391321959

Ministerstvo Zdravotnictví Ceské Republiky

Grant: NU20‐02‐00052

Ministerstvo Zdravotnictví Ceské Republiky

Grant: NU22‐02‐00161

Ministry of Health of the Czech Republic

Grant: NU20-02-00052

Ministry of Health of the Czech Republic

Grant: NU22-02-00161

Grant Agency of Charles University (GAUK)

Grant: 304121

Project National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES), funded by the European Union-Next Generation EU

Grant: LX22NPO5104

FWCI

1.15

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.1172

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.1172

publisherhttps://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.1172

journalhttps://doi.org/10.1002/prp2.1172

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38284173

Fields of Study

Pulmonary Hypertension Research and TreatmentsHeart Failure Treatment and ManagementPhosphodiesterase function and regulationAnimalsMaleRatsAngiotensin-Converting Enzyme InhibitorsCardiomegalyHeart FailureVentricular RemodelingPhosphodiesterase 5 Inhibitors

MeSH Terms

Angiotensin-Converting Enzyme InhibitorsAngiotensinsAnimalsCardiomegalyHeart FailureMaleVentricular RemodelingRatsCyclic Nucleotide Phosphodiesterases, Type 5Phosphodiesterase 5 Inhibitors

Keywords

Internal medicineMedicineHeart failureCardiologycGMP-specific phosphodiesterase type 5VentriclePressure overloadCyclic guanosine monophosphateVentricular remodelingEndocrinologyVolume overloadMuscle hypertrophyRenal functionLeft ventricular hypertrophyAngiotensin-converting enzymeSildenafilBlood pressureRatsRight VentriclePhosphodiesterase-5 Inhibition

Sustainable Development Goals

SDG 0: Good health and well-being